Antibiotic research and development: business as usual?

  title={Antibiotic research and development: business as usual?},
  author={Stephan Harbarth and Ursula Theuretzbacher and Judith Hackett},
  journal={The Journal of antimicrobial chemotherapy},
  volume={70 6},
The global burden of antibiotic resistance is tremendous and, without new anti-infective strategies, will continue to increase in the coming decades. Despite the growing need for new antibiotics, few pharmaceutical companies today retain active antibacterial drug discovery programmes. One reason is that it is scientifically challenging to discover new antibiotics that are active against the antibiotic-resistant bacteria of current clinical concern. However, the main hurdle is diminishing… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 29 times over the past 90 days. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.
18 Citations
13 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 18 extracted citations


Publications referenced by this paper.

Similar Papers

Loading similar papers…